Update: influenza activity--United States, 2004-05 season

    Insights

    Influenza activity increased in the US starting mid-December, with 45 states reporting infections. An Investigational New Drug protocol will allow the use of additional imported influenza vaccine due to supply shortages.

    Area of Science:

    • Public Health
    • Epidemiology
    • Virology

    Background:

    • Influenza activity in the United States was low from October to early December 2004.
    • Activity began to increase steadily in mid-December, indicating the season had not yet peaked.
    • Laboratory-confirmed influenza infections were reported across 45 states.

    Purpose of the Study:

    • To summarize influenza activity in the US from October 3, 2004, to January 1, 2005.
    • To provide information on the availability of additional influenza vaccine.
    • To address the influenza vaccine supply shortage.

    Main Methods:

    • Surveillance data analysis for influenza activity.
    • Antigenic characterization of circulating influenza viruses.
    • Description of the procurement and administration of imported influenza vaccine.

    Main Results:

    • Influenza activity increased significantly after mid-December 2004.
    • Circulating influenza viruses were antigenically well-matched to the 2004-05 vaccine strains.
    • 1.2 million doses of inactivated influenza vaccine were purchased from GlaxoSmithKline (GSK) to supplement the domestic supply.

    Conclusions:

    • The 2004-05 influenza season activity increased after mid-December.
    • A vaccine supply shortage necessitated the use of imported GSK vaccine under an Investigational New Drug (IND) protocol.
    • The antigenic match between vaccine strains and circulating viruses was favorable.

    Related Concept Videos

    Influenza01:27

    Influenza

    Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
    Vaccinations01:51

    Vaccinations

    Overview
    Inhibitors Of Virion Release01:25

    Inhibitors Of Virion Release

    Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
    Infectious Diseases and Their Occurrence01:28

    Infectious Diseases and Their Occurrence

    Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable temporal or...
    Smallpox01:24

    Smallpox

    Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.